Please login to the form below
NeuroRx
This page shows the latest NeuroRx news and features for those working in and with pharma, biotech and healthcare.
Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
Relief Therapeutics has announced that its NeuroRX-partnered COVID-19 drug RLF-100 met the survival threshold in intensive care patients and added that it expects detailed trial data this year. ... Relief and NeuroRx are still awaiting the detailed
Latest news
-
Relief Therapeutics seeks US emergency approval for COVID-19 drug
Relief Therapeutics and its development partner NeuroRx have announced the submission of their potential COVID-19 med to the US Food and Drug Administration (FDA), seeking an emergency use authorisation (EUA). ... We continue to work tirelessly with our
-
NeuroRx, Relief Therapeutics’ COVID-19 drug demonstrates early potential
Drug produced rapid recovery in critically-ill patients. NeuroRx and Relief Therapeutics have announced that their investigational therapeutic RLF-100 produces rapid recovery from respiratory failure in critically-ill COVID-19 ... No other antiviral
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Engaging KOLs and Gaining Insights in Pharma's New Normal
- That ‘don’t’ impress me much
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
- How the Royal Society’s EiR programme can help to drive UK innovation
- ...
